Concert Pharma Deuruxolitinib significantly improves scalp hair regrowth in Alopecia areata, reveals data Ruchika Sharma21 March 2023 1:15 PM ISTDeuruxolitinib is an investigational oral selective inhibitor of Janus kinases JAK1 and JAK2.
Sun Pharma concludes acquisition of Concert Pharma Ruchika Sharma7 March 2023 2:30 PM ISTAcquisition adds Deuruxolitinib for the treatment of alopecia areata, to Sun Pharma’s global dermatology portfolio
Alopecia Areata patients have higher rates of anxiety and depression, says study Aditi3 Feb 2023 8:00 PM ISTThe study demonstrated a strong relationship between Alopecia Areata (AA) patients and two to three times higher anxiety and depression rates than the...
Sun Pharma to buy Concert Pharma for Rs 4678 crore Ruchika Sharma20 Jan 2023 12:26 PM IST"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the first half of 2023," the...
Inflammatory bowel disease associated with chronic inflammatory skin diseases Dr.Niharika Harsha B9 Dec 2022 8:00 PM ISTA new study revealed that inflammatory bowel disease was associated with various chronic inflammatory skin diseases. IBD incidence was increased in...
Marie Antoinette syndrome following COVID-19 vaccination Dr Manoj Kumar Nayak27 Oct 2022 7:30 PM ISTMarie Antoinette syndrome following COVID-19 vaccination Marie Antoinette syndrome refers to a condition in which scalp hair suddenly turns...
USFDA accepts regulatory submission for Pfizer alopecia areata treatment Ritlecitinib Ruchika Sharma10 Sept 2022 5:15 PM ISTAlopecia areata is an autoimmune disease that has an underlying immuno-inflammatory pathogenesis and develops when the immune system attacks the...
Alopecia areata patients are at risk for developing cardiovascular conditions, study says Medha Baranwal20 Jun 2022 7:30 PM ISTPoland: Patients with alopecia areata (AA) at risk of endothelial dysfunction, according to results of a case-control study. The study found that AA...
FDA approves Olumiant as first systemic therapy for treatment of alopecia areata Dr. Kamal Kant Kohli15 Jun 2022 9:00 AM ISTThe U.S. Food and Drug Administration has approved Olumiant as first systemic therapy for the treatment of alopecia areata.Olumiant...
FIRST: Eli Lilly gets USFDA nod for alopecia areata pill Olumiant Ruchika Sharma14 Jun 2022 1:00 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly and is available through specialty pharmacies nationwide.
Investigational JAK inhibitor found safe, effective in moderate to severe alopecia areata in phase 3 study Dr. Kamal Kant Kohli26 May 2022 8:00 PM ISTAlopecia areata is an autoimmune disorder that results in patchy or complete scalp hair loss. CTP-543 is an investigational oral selective inhibitor...
Patients with Psoriasis at greater risk of Developing Alopecia Areata Dr. Shravani Dali9 May 2022 9:00 AM ISTPatients with Psoriasis are at a greater risk of Developing Alopecia Areata, according to a recent study published in The Journal of Dermatology. ...
